Johnson & Johnson
All Topics
Find news about people
Find news on alumni of any org
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed

News on Johnson & Johnson

... patient-assistance charity, federal prosecutors said Thursday. Actelion, which was acquired by Johnson & Johnson in 2017 and makes expensive drugs to treat a rare lung ...
... AG., Teva Pharmaceuticals Industries Limited, Novartis AG, CELGENE CORPORATION, Sanofi S.A., JOHNSON & JOHNSON, AMAG Pharmaceuticals and Shire plc., among others. Executive Summary Big pharma ...
... (2018-2027). These emerging drugs mainly include Siponimod (BAF312; Novartis), Ponesimod (ACT-128800; Johnson and Johnson), Ozanimod (RPC1063; Celgene), Ofatumumab (Novartis), Ublituximab (TG Therapeutics), ALKS 8700 (Alkermes ...
... MRD negative, this period was even longer at 24 months. RELATED: Johnson & Johnson CAR-T partner GenScript yo-yos on fake data allegations But the study ...
... elevation, kidney problems or infections.7 About the Janssen Pharmaceutical Companies of Johnson & Johnson At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are ...
... first graduates of our doctoral program were some young leaders from Johnson and Johnson. They're in their early 40s, maxed out in a division within ...
Subscribe now for full coverage on Johnson & Johnson
Start My Free Trial